[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPS52130922A - Remedy for cerebral blood flow disorders containing coenzyme-q as main ingredient - Google Patents

Remedy for cerebral blood flow disorders containing coenzyme-q as main ingredient

Info

Publication number
JPS52130922A
JPS52130922A JP4649076A JP4649076A JPS52130922A JP S52130922 A JPS52130922 A JP S52130922A JP 4649076 A JP4649076 A JP 4649076A JP 4649076 A JP4649076 A JP 4649076A JP S52130922 A JPS52130922 A JP S52130922A
Authority
JP
Japan
Prior art keywords
main ingredient
remedy
blood flow
cerebral blood
containing coenzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4649076A
Other languages
Japanese (ja)
Other versions
JPS5938203B2 (en
Inventor
Isao Iwahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority to JP4649076A priority Critical patent/JPS5938203B2/en
Publication of JPS52130922A publication Critical patent/JPS52130922A/en
Publication of JPS5938203B2 publication Critical patent/JPS5938203B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE: A drug containing coenzyme-Q as the main ingredient and useful for the treatment of headache, dizziness, abnormal smell, numbness of the limbs, clouding of consciousness, etc. abserved in apoploxy, arterioscrelosis, sequela of external wounds in the head, etc.
COPYRIGHT: (C)1977,JPO&Japio
JP4649076A 1976-04-26 1976-04-26 A therapeutic agent for cerebral circulation disorders whose main ingredient is coenzyme Q. Expired JPS5938203B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4649076A JPS5938203B2 (en) 1976-04-26 1976-04-26 A therapeutic agent for cerebral circulation disorders whose main ingredient is coenzyme Q.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4649076A JPS5938203B2 (en) 1976-04-26 1976-04-26 A therapeutic agent for cerebral circulation disorders whose main ingredient is coenzyme Q.

Publications (2)

Publication Number Publication Date
JPS52130922A true JPS52130922A (en) 1977-11-02
JPS5938203B2 JPS5938203B2 (en) 1984-09-14

Family

ID=12748645

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4649076A Expired JPS5938203B2 (en) 1976-04-26 1976-04-26 A therapeutic agent for cerebral circulation disorders whose main ingredient is coenzyme Q.

Country Status (1)

Country Link
JP (1) JPS5938203B2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3625877A1 (en) * 1985-08-02 1987-02-05 Seuref Ag PHARMACEUTICAL COMPOSITIONS WITH VASODILATORIC AND ANTIANOXIC ACTIVITIES
WO2000047185A1 (en) * 1999-02-11 2000-08-17 Mse Pharmazeutika Gmbh SPRAY CONTAINING UBIQUINONE Q¿n?
JP2006045187A (en) * 2003-12-25 2006-02-16 Bio Igaku Kenkyusho Kk Therapeutic agent for internal organ failure
WO2009111543A3 (en) * 2008-03-05 2009-12-30 Edison Pharmaceuticals, Inc. Treatment of hearing and balance impairments with redox-active therapeutics
CN102647981A (en) * 2009-08-26 2012-08-22 爱迪生制药有限公司 Methods for the prevention and treatment of cerebral ischemia
JP5103374B2 (en) * 2006-03-13 2012-12-19 株式会社カネカ Cardiac dysfunction improving agent or cardiac function maintaining agent
US9932286B2 (en) 2006-02-22 2018-04-03 Bioelectron Technology Corporation Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US10105325B2 (en) 2008-09-10 2018-10-23 Bioelectron Technology Corporation Treatment of pervasive developmental disorders with redox-active therapeutics
US10703701B2 (en) 2015-12-17 2020-07-07 Ptc Therapeutics, Inc. Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
US11021424B2 (en) 2005-06-01 2021-06-01 Ptc Therapeutics, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03129202U (en) * 1990-04-11 1991-12-25
JPH0537094U (en) * 1991-10-23 1993-05-21 四国化工機株式会社 Filling device for filled viscous food

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3625877A1 (en) * 1985-08-02 1987-02-05 Seuref Ag PHARMACEUTICAL COMPOSITIONS WITH VASODILATORIC AND ANTIANOXIC ACTIVITIES
WO2000047185A1 (en) * 1999-02-11 2000-08-17 Mse Pharmazeutika Gmbh SPRAY CONTAINING UBIQUINONE Q¿n?
JP2006045187A (en) * 2003-12-25 2006-02-16 Bio Igaku Kenkyusho Kk Therapeutic agent for internal organ failure
US11021424B2 (en) 2005-06-01 2021-06-01 Ptc Therapeutics, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US9932286B2 (en) 2006-02-22 2018-04-03 Bioelectron Technology Corporation Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
JP5103374B2 (en) * 2006-03-13 2012-12-19 株式会社カネカ Cardiac dysfunction improving agent or cardiac function maintaining agent
WO2009111543A3 (en) * 2008-03-05 2009-12-30 Edison Pharmaceuticals, Inc. Treatment of hearing and balance impairments with redox-active therapeutics
US10736857B2 (en) 2008-09-10 2020-08-11 Ptc Therapeutics, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
US10105325B2 (en) 2008-09-10 2018-10-23 Bioelectron Technology Corporation Treatment of pervasive developmental disorders with redox-active therapeutics
JP2013503168A (en) * 2009-08-26 2013-01-31 エジソン ファーマシューティカルズ， インコーポレイテッド Method for preventing or treating cerebral ischemia
CN102647981A (en) * 2009-08-26 2012-08-22 爱迪生制药有限公司 Methods for the prevention and treatment of cerebral ischemia
US10703701B2 (en) 2015-12-17 2020-07-07 Ptc Therapeutics, Inc. Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
US10981855B2 (en) 2015-12-17 2021-04-20 Ptc Therapeutics, Inc. Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
US11680034B2 (en) 2015-12-17 2023-06-20 Ptc Therapeutics, Inc. Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

Also Published As

Publication number Publication date
JPS5938203B2 (en) 1984-09-14

Similar Documents

Publication Publication Date Title
FI892762A (en) FOERFARANDE FOER FRAMSTAELLNING AV ESTROGENPRODUKT.
ES2077530A1 (en) Pharmaceutical products for curing tumorous diseases and process for preparing same
HUT37418A (en) Process for producing new 2,2'-imino-bis/ethanol/ derivatives and pharmaceutical compositions sontaining them as active agents
IT1138543B (en) THE THERAPEUTIC APPLICATION OF THE 4,5,6,7-TETRAIDROISOSSAZOLO (5,4-C) PYRIDIN-3-OLO DERIVATIVES AS MYOTONOLYTICS
DE2862409D1 (en) Pharmaceutical formulations comprising 1-substituted imidazoles, 1-substituted imidazoles and 1-substituted imidazoles for use in the treatment or prophylaxis of thrombo-embolic disorders
IT8320301A0 (en) LIQUID PREPARATIONS OF DIHYDROPYRIDINES, PROCEDURE FOR THEIR PREPARATION AS WELL AS THEIR USE IN THE TREATMENT OF DISEASES.
JPS52130922A (en) Remedy for cerebral blood flow disorders containing coenzyme-q as main ingredient
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
JPS5231839A (en) Drug for cosmetics and permanent wave in combination
IT1170214B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES
IL51403A0 (en) 1,2-dithiole derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
DE3062981D1 (en) Alkyl-urea derivatives for the treatment of lipometabolic diseases; process for their preparation, their use in medicaments for the treatment of lipometabolic disorders, medicaments containing them, process for the preparation of the medicaments, and some alkyl-urea derivatives
JPS6434909A (en) Cosmetic
HUT57178A (en) Process for producing new retinoids and paharmaceutical compositions comprising such active ingredient
SE8400723D0 (en) PHARMACEUTICAL COMPOSITION
IT8248666A0 (en) PROCEDURE FOR PRODUCING THE GLYCOSA MINOGLICANS DERMATANSULFATE AND EPARAN SULFATE, SUBSTANTIALLY PURE AND FOR PHARMACEUTICAL USE
DE59107336D1 (en) Oligosaccharide derivatives and their use in medicinal products
PT76247B (en) Process for preparing antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes and of pharmaceutical compositions containing the same
DE3481057D1 (en) 2-SULFAMOYLBENZO (B) THIOPHENE DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF INCREASED EYE PRESSURE.
DE3479728D1 (en) Derivatives of thiophenesulfonamide, their preparation and pharmaceutical composition for the topical treatment of elevated intraocular pressure
ZA902627B (en) Substituted 1,8-naphthyridines
HU9201358D0 (en) 2-amino-pirimidine-4-carboxamide derivatives, process for their production and for the production of medical preparations containing them as active agents
ZA81473B (en) 5-amino-tetayole derivatives of retinoic acids, their preparation and pharmaceutical formulations containg these derivatives
IT8319600A0 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF GLAUCOMA.
ATE69949T1 (en) LIPOSOMES WITH INHALATION ALLERGENS FOR THE TREATMENT OF ALLERGIES, METHOD FOR THEIR MANUFACTURE AND MEDICATIONS CONTAINING THEM.